- R&D
- Clinical Diagnosis
- News
- Company
Quick Biology Inc. is a pioneering CLIA-certified biotech company that has been at the forefront of delivering exceptional services and groundbreaking outcomes in the field of Next-Generation Sequencing (NGS) and molecular diagnosis.
Our journey began in 2015 in Pasadena, CA, and in 2022, we relocated to Monrovia, CA, where we continue to thrive and expand.
Our high-throughput genomic center equipped with all major next-generation sequencing. QB provides state-of-the-art genomics technologies, comprehensive services, and specialized expertise enabling these services in a cost-effective and timely manner to serve basic science and translational/clinical research. QB's service included, but not limited to, RNA sequencing, whole exome sequencing, whole genome sequencing, ATAC sequencing, and single cell RNA sequencing.
1.Scientific Research
Quick Biology supports scientific research by offering state-of-the-art NGS solutions and molecular diagnostics. We collaborate with leading institutions, including UCLA, City of Hope, Cedars-Sinai, Caltech, and other renowned scientific organizations. We also provide services to government institutes like NIH and USDA.
2.Clinical Diagnosis
We are proud to be one of the few clinical laboratories in the United States offering NGS services and molecular diagnostics. Our CLIA quality genetic testing services encompass single gene tests, rare disease tests, and multiomics tests, ensuring accurate and reliable results for healthcare professionals and patients.
3. Biopharma Services
Quick Biology is a trusted partner for biopharmaceutical companies, providing tailored solutions to support drug discovery and development. Our cutting-edge technologies and expertise enable biopharma clients to accelerate their research and achieve better outcomes.
Quick Biology's reach extends to a diverse range of stakeholders, including: